Related references
Note: Only part of the references are listed.Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid
Alexandra M. Miller et al.
NATURE (2019)
5-ALA-assisted stereotactic brain tumor biopsy improve diagnostic yield
Ben Shofty et al.
EJSO (2019)
The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients
Craig Horbinski et al.
NEURO-ONCOLOGY (2019)
Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid
Francisco Martinez-Ricarte et al.
CLINICAL CANCER RESEARCH (2018)
Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations
Jesse J. Salk et al.
NATURE REVIEWS GENETICS (2018)
FGFR1 actionable mutations, molecular specificities, and outcome of adult midline gliomas
Alberto Picca et al.
NEUROLOGY (2018)
cIMPACT-NOW update 3: recommended diagnostic criteria for Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV
Daniel J. Brat et al.
ACTA NEUROPATHOLOGICA (2018)
Characteristics of H3 K27M-mutant gliomas in adults
David Meyronet et al.
NEURO-ONCOLOGY (2017)
Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations
David A. Solomon et al.
BRAIN PATHOLOGY (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
TERT promoter mutations in primary central nervous system lymphoma are associated with spatial distribution in the splenium
Aurelie Bruno et al.
ACTA NEUROPATHOLOGICA (2015)
Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation
Dong-Sheng Huang et al.
EUROPEAN JOURNAL OF CANCER (2015)
A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer
Gerard A. Silvestri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Complications Following Stereotactic Needle Biopsy of Intracranial Tumors
Hani Malone et al.
WORLD NEUROSURGERY (2015)
Re-evaluation of nondiagnostic biopsies of suspected low-grade glioma using isocitrate dehydrogenase 1 mutation immunohistochemistry
Mark D. Anderson et al.
NEURO-ONCOLOGY (2013)
Frequency of TERT promoter mutations in human cancers
Joao Vinagre et al.
NATURE COMMUNICATIONS (2013)
Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas
Alberto Gonzalez-Aguilar et al.
CLINICAL CANCER RESEARCH (2012)
Cost Impact of Molecular Testing for Indeterminate Thyroid Nodule Fine-Needle Aspiration Biopsies
Linwah Yip et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
A Multiplex SNaPshot Assay as a Rapid Method for Detecting KRAS and BRAF Mutations in Advanced Colorectal Cancers
Sandrine Magnin et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2011)
Application of Mutant IDH1 Antibody to Differentiate Diffuse Glioma From Nonneoplastic Central Nervous System Lesions and Therapy-induced Changes
David Capper et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Share Paper
